1-Methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 4, 2003, Pages 409-411

  Lee, Myung Koo ^a   Hwang, Bang Yeon ^b   Lee, Seon A ^a   Oh, Gab Jin ^c   Choi, Woo Hoi ^a   Hong, Seong Su ^a   Lee, Kyong Soon ^a   Ro, Jai Seup ^a  

^a Chungbuk National University   (South Korea)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Samil Pharmaceutical Co Ltd   (South Korea)

Author keywords

1 methyl 2 undecyl 4(1H) quinolone; Evodia rutaecarpa; Monoamine oxidase inhibitor

Indexed keywords

1 METHYL 2 UNDECYL 4(1H) QUINOLONE; CATECHOLAMINE; CHLORINE DERIVATIVE; EVODIA FRUIT; MONOAMINE OXIDASE B INHIBITOR; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE INHIBITOR; PLANT EXTRACT; QUINOLONE DERIVATIVE;

ARTICLE; DIALYSIS; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME INHIBITION; INCUBATION TIME; KINETICS; NERVE CELL; ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; FRUIT; ISOLATION AND PURIFICATION; METABOLISM; MOUSE;

ANIMALS; BRAIN; EVODIA; FRUIT; MICE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PLANT EXTRACTS; QUINOLONES;

EID: 0242317718     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.409     Document Type: Article

References (28)

1. Nagatsu T., Yamamoto T., Harada M., Enzymologia, 39, 15-25 (1970).
2. Tipton K. F., Cell Biochem. Funct., 4, 79-87 (1986).
3. Tipton K. F., O'Carrol A. M., McCrodden J. M., J. Neural Transm. (Suppl.), 23, 25-35 (1987).
4. Bach A. W., Lan N. C., Johnson D. L., Abell C. W., Bembenek M. E., Kwan S. W., Seeburg P. H., Shin J. C., Proc. Natl. Acad. Sci. U.S.A., 85, 4934-4938 (1988).
5. Kalgutkar A. S., Castagnoli N. J., Testa B., Med. Res. Rev., 15, 325-388 (1995).
6. Fowler C. J., Ross S. B., Med. Res. Rev., 4, 323-358 (1984).
7. Thomas T., Neurobiol. Aging, 21, 343-348 (2000).
8. Naoi M., Nagatsu T., Life Sci., 40, 1075-1082 (1987).
9. Mitsui N., Noro T., Kuroyanagi M., Miyase T., Umehara K., Ueno A., Chem. Pharm. Bull., 37, 363-366 (1989).
10. Thull U., Kneubuhler S., Gaillard P., Carrupt P. A., Testa B., Altomare C., Carotti A., Jenner P., McNaught K. St. P., Biochem. Pharmacol., 50, 869-877 (1995).
11. Bembenek M. E., Abell C. W., Chrisey L. A., Rozwadowska M. D., Gessner W., Brossi A., J. Med. Chem., 33, 147-152 (1990).
12. Ro J. S., Lee S. S., Lee K. S., Lee M. K., Life Sci., 70, 639-645 (2001).
13. Gnerre C., Catto M., Leonetti F., Weber P., Carrupt P. A., Altomare C., Carotti A., Testa B., J. Med. Chem., 43, 4747-4758 (2000).
14. Huong D. T., Choi H. C., Rho T. C., Lee H. S., Lee M. K., Kim Y. H., Arch. Pharm. Res., 22, 324-326 (1999).
15. Suzuki O., Katsumata Y., Oya M., Chari V. M., Vermes B., Wagner H., Hostettmann K., Planta Med., 42, 17-21 (1981).
16. Ohishi N., Suzuki T., Ogasawara T., Yagi K., J. Mol. Catal. B-Enzym., 10, 291-294 (2000).
17. Tang Y. Q., Feng X. Z., Huang L., Phytochem., 43, 719-722 (1996).
18. Sugimoto T., Miyase T., Kuroyanagi M., Ueno A., Chem. Pharm. Bull., 36, 4453-4461 (1988).
19. Giller E., Jatlow P., Bialos D., Harkness L., Docherty J., Psychiatry Res., 2, 259-265 (1980).
20. Roth J. A., J. Neurochem., 27, 1107-1112 (1976).
21. Sheehan D. V., J. Clin. Psychiat., 45, 29-36 (1984).
22. Walsh B. T., Gladis M., Roose S. P., Stewart J. W., Stetner F., Glassman A. H., Arch. Gen. Psychiat., 45, 471-475 (1988).
23. Liebowitz M. R., Schneier F. R., Hollander E., Welkowitz L. A., Saoud J. B., Feerick J., Campeas R., Fallon B. A., Street L., Gitow A., J. Clin. Psychiat., 52, 10-15 (1991).
24. Tetrud J. W., Langston J. W., Science, 245, 519-522 (1989).
25. Sugimoto T., Miyase T., Kuroyanagi M., Ueno A., Chem. Pharm. Bull., 36, 4453-4461 (1988).
26. Naoi M., Nagatsu T., J. Neurochem., 46, 655-657 (1986).
27. Kraml M., Biochem. Pharmacol., 14, 1684-1686 (1965).
28. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).